Table of Content

1 Gabapentin Drug Market Overview
1.1 Product Overview and Scope of Gabapentin Drug
1.2 Gabapentin Drug Segment by Type
1.2.1 Global Gabapentin Drug Market Value Comparison by Type (2024-2034)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Gabapentin Drug Segment by Application
1.3.1 Global Gabapentin Drug Market Value by Application: (2024-2034)
1.3.2 Postherpetic Neuralgia in Adults
1.3.3 Partial Onset Seizures
1.3.4 Others
1.4 Global Gabapentin Drug Market Size Estimates and Forecasts
1.4.1 Global Gabapentin Drug Revenue 2018-2029
1.4.2 Global Gabapentin Drug Sales 2018-2029
1.4.3 Global Gabapentin Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gabapentin Drug Market Competition by Manufacturers
2.1 Global Gabapentin Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Gabapentin Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Gabapentin Drug Average Price by Manufacturers (2018-2024)
2.4 Global Gabapentin Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Gabapentin Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gabapentin Drug, Product Type & Application
2.7 Gabapentin Drug Market Competitive Situation and Trends
2.7.1 Gabapentin Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gabapentin Drug Players Market Share by Revenue
2.7.3 Global Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gabapentin Drug Retrospective Market Scenario by Region
3.1 Global Gabapentin Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gabapentin Drug Global Gabapentin Drug Sales by Region: 2018-2029
3.2.1 Global Gabapentin Drug Sales by Region: 2018-2024
3.2.2 Global Gabapentin Drug Sales by Region: 2024-2029
3.3 Global Gabapentin Drug Global Gabapentin Drug Revenue by Region: 2018-2029
3.3.1 Global Gabapentin Drug Revenue by Region: 2018-2024
3.3.2 Global Gabapentin Drug Revenue by Region: 2024-2029
3.4 North America Gabapentin Drug Market Facts & Figures by Country
3.4.1 North America Gabapentin Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gabapentin Drug Sales by Country (2018-2029)
3.4.3 North America Gabapentin Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gabapentin Drug Market Facts & Figures by Country
3.5.1 Europe Gabapentin Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gabapentin Drug Sales by Country (2018-2029)
3.5.3 Europe Gabapentin Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gabapentin Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Gabapentin Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gabapentin Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Gabapentin Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gabapentin Drug Market Facts & Figures by Country
3.7.1 Latin America Gabapentin Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gabapentin Drug Sales by Country (2018-2029)
3.7.3 Latin America Gabapentin Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gabapentin Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Gabapentin Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gabapentin Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gabapentin Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gabapentin Drug Sales by Type (2018-2029)
4.1.1 Global Gabapentin Drug Sales by Type (2018-2024)
4.1.2 Global Gabapentin Drug Sales by Type (2024-2029)
4.1.3 Global Gabapentin Drug Sales Market Share by Type (2018-2029)
4.2 Global Gabapentin Drug Revenue by Type (2018-2029)
4.2.1 Global Gabapentin Drug Revenue by Type (2018-2024)
4.2.2 Global Gabapentin Drug Revenue by Type (2024-2029)
4.2.3 Global Gabapentin Drug Revenue Market Share by Type (2018-2029)
4.3 Global Gabapentin Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gabapentin Drug Sales by Application (2018-2029)
5.1.1 Global Gabapentin Drug Sales by Application (2018-2024)
5.1.2 Global Gabapentin Drug Sales by Application (2024-2029)
5.1.3 Global Gabapentin Drug Sales Market Share by Application (2018-2029)
5.2 Global Gabapentin Drug Revenue by Application (2018-2029)
5.2.1 Global Gabapentin Drug Revenue by Application (2018-2024)
5.2.2 Global Gabapentin Drug Revenue by Application (2024-2029)
5.2.3 Global Gabapentin Drug Revenue Market Share by Application (2018-2029)
5.3 Global Gabapentin Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Gabapentin Drug Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Depomed
6.2.1 Depomed Corporation Information
6.2.2 Depomed Description and Business Overview
6.2.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Depomed Gabapentin Drug Product Portfolio
6.2.5 Depomed Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Corporation Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Apotex Gabapentin Drug Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Teva Gabapentin Drug Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Acella Pharmaceuticals
6.5.1 Acella Pharmaceuticals Corporation Information
6.5.2 Acella Pharmaceuticals Description and Business Overview
6.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Acella Pharmaceuticals Gabapentin Drug Product Portfolio
6.5.5 Acella Pharmaceuticals Recent Developments/Updates
6.6 Taro
6.6.1 Taro Corporation Information
6.6.2 Taro Description and Business Overview
6.6.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Taro Gabapentin Drug Product Portfolio
6.6.5 Taro Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sun Pharmaceutical Gabapentin Drug Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Glenmark
6.8.1 Glenmark Corporation Information
6.8.2 Glenmark Description and Business Overview
6.8.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Glenmark Gabapentin Drug Product Portfolio
6.8.5 Glenmark Recent Developments/Updates
6.9 Amneal Pharmaceuticals
6.9.1 Amneal Pharmaceuticals Corporation Information
6.9.2 Amneal Pharmaceuticals Description and Business Overview
6.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Amneal Pharmaceuticals Gabapentin Drug Product Portfolio
6.9.5 Amneal Pharmaceuticals Recent Developments/Updates
6.10 Aurobindo Pharma
6.10.1 Aurobindo Pharma Corporation Information
6.10.2 Aurobindo Pharma Description and Business Overview
6.10.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Aurobindo Pharma Gabapentin Drug Product Portfolio
6.10.5 Aurobindo Pharma Recent Developments/Updates
6.11 Zydus Pharmaceuticals
6.11.1 Zydus Pharmaceuticals Corporation Information
6.11.2 Zydus Pharmaceuticals Gabapentin Drug Description and Business Overview
6.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Zydus Pharmaceuticals Gabapentin Drug Product Portfolio
6.11.5 Zydus Pharmaceuticals Recent Developments/Updates
6.12 Hi-Tech Pharmaceuticals
6.12.1 Hi-Tech Pharmaceuticals Corporation Information
6.12.2 Hi-Tech Pharmaceuticals Gabapentin Drug Description and Business Overview
6.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio
6.12.5 Hi-Tech Pharmaceuticals Recent Developments/Updates
6.13 Marksans Pharma
6.13.1 Marksans Pharma Corporation Information
6.13.2 Marksans Pharma Gabapentin Drug Description and Business Overview
6.13.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Marksans Pharma Gabapentin Drug Product Portfolio
6.13.5 Marksans Pharma Recent Developments/Updates
6.14 Mylan
6.14.1 Mylan Corporation Information
6.14.2 Mylan Gabapentin Drug Description and Business Overview
6.14.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Mylan Gabapentin Drug Product Portfolio
6.14.5 Mylan Recent Developments/Updates
6.15 InvaGen Pharmaceuticals
6.15.1 InvaGen Pharmaceuticals Corporation Information
6.15.2 InvaGen Pharmaceuticals Gabapentin Drug Description and Business Overview
6.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.15.4 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio
6.15.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.16 Alkem Laboratories
6.16.1 Alkem Laboratories Corporation Information
6.16.2 Alkem Laboratories Gabapentin Drug Description and Business Overview
6.16.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Alkem Laboratories Gabapentin Drug Product Portfolio
6.16.5 Alkem Laboratories Recent Developments/Updates
6.17 Tris Pharma
6.17.1 Tris Pharma Corporation Information
6.17.2 Tris Pharma Gabapentin Drug Description and Business Overview
6.17.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Tris Pharma Gabapentin Drug Product Portfolio
6.17.5 Tris Pharma Recent Developments/Updates
6.18 ACI HealthCare Limited
6.18.1 ACI HealthCare Limited Corporation Information
6.18.2 ACI HealthCare Limited Gabapentin Drug Description and Business Overview
6.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.18.4 ACI HealthCare Limited Gabapentin Drug Product Portfolio
6.18.5 ACI HealthCare Limited Recent Developments/Updates
6.19 Jiangsu Hengrui Medicine
6.19.1 Jiangsu Hengrui Medicine Corporation Information
6.19.2 Jiangsu Hengrui Medicine Gabapentin Drug Description and Business Overview
6.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio
6.19.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.20 CSPC Ouyi Pharmaceutical
6.20.1 CSPC Ouyi Pharmaceutical Corporation Information
6.20.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Description and Business Overview
6.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio
6.20.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.21 Sciegen Pharmaceuticals
6.21.1 Sciegen Pharmaceuticals Corporation Information
6.21.2 Sciegen Pharmaceuticals Gabapentin Drug Description and Business Overview
6.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio
6.21.5 Sciegen Pharmaceuticals Recent Developments/Updates
6.22 Epic Pharma
6.22.1 Epic Pharma Corporation Information
6.22.2 Epic Pharma Gabapentin Drug Description and Business Overview
6.22.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Epic Pharma Gabapentin Drug Product Portfolio
6.22.5 Epic Pharma Recent Developments/Updates
6.23 Lupin Limited
6.23.1 Lupin Limited Corporation Information
6.23.2 Lupin Limited Gabapentin Drug Description and Business Overview
6.23.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Lupin Limited Gabapentin Drug Product Portfolio
6.23.5 Lupin Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gabapentin Drug Industry Chain Analysis
7.2 Gabapentin Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gabapentin Drug Production Mode & Process
7.4 Gabapentin Drug Sales and Marketing
7.4.1 Gabapentin Drug Sales Channels
7.4.2 Gabapentin Drug Distributors
7.5 Gabapentin Drug Customers
8 Gabapentin Drug Market Dynamics
8.1 Gabapentin Drug Industry Trends
8.2 Gabapentin Drug Market Drivers
8.3 Gabapentin Drug Market Challenges
8.4 Gabapentin Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Gabapentin Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Gabapentin Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Gabapentin Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gabapentin Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Gabapentin Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Gabapentin Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Gabapentin Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Gabapentin Drug Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Gabapentin Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Gabapentin Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gabapentin Drug, Product Type & Application
Table 12. Global Key Manufacturers of Gabapentin Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gabapentin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gabapentin Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gabapentin Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Gabapentin Drug Sales Market Share by Region (2018-2024)
Table 19. Global Gabapentin Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Gabapentin Drug Sales Market Share by Region (2024-2029)
Table 21. Global Gabapentin Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Gabapentin Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Gabapentin Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gabapentin Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Gabapentin Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Gabapentin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Gabapentin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gabapentin Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gabapentin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Gabapentin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gabapentin Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gabapentin Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Gabapentin Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gabapentin Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Gabapentin Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gabapentin Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gabapentin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Gabapentin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gabapentin Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gabapentin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Gabapentin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gabapentin Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Gabapentin Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Gabapentin Drug Sales Market Share by Type (2018-2024)
Table 53. Global Gabapentin Drug Sales Market Share by Type (2024-2029)
Table 54. Global Gabapentin Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Gabapentin Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gabapentin Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Gabapentin Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Gabapentin Drug Price (USD/Unit) by Type (2018-2024)
Table 59. Global Gabapentin Drug Price (USD/Unit) by Type (2024-2029)
Table 60. Global Gabapentin Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Gabapentin Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Gabapentin Drug Sales Market Share by Application (2018-2024)
Table 63. Global Gabapentin Drug Sales Market Share by Application (2024-2029)
Table 64. Global Gabapentin Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Gabapentin Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gabapentin Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Gabapentin Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Gabapentin Drug Price (USD/Unit) by Application (2018-2024)
Table 69. Global Gabapentin Drug Price (USD/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Pfizer Gabapentin Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Depomed Corporation Information
Table 76. Depomed Description and Business Overview
Table 77. Depomed Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Depomed Gabapentin Drug Product
Table 79. Depomed Recent Developments/Updates
Table 80. Apotex Corporation Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Apotex Gabapentin Drug Product
Table 84. Apotex Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Teva Gabapentin Drug Product
Table 89. Teva Recent Developments/Updates
Table 90. Acella Pharmaceuticals Corporation Information
Table 91. Acella Pharmaceuticals Description and Business Overview
Table 92. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Acella Pharmaceuticals Gabapentin Drug Product
Table 94. Acella Pharmaceuticals Recent Developments/Updates
Table 95. Taro Corporation Information
Table 96. Taro Description and Business Overview
Table 97. Taro Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Taro Gabapentin Drug Product
Table 99. Taro Recent Developments/Updates
Table 100. Sun Pharmaceutical Corporation Information
Table 101. Sun Pharmaceutical Description and Business Overview
Table 102. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Sun Pharmaceutical Gabapentin Drug Product
Table 104. Sun Pharmaceutical Recent Developments/Updates
Table 105. Glenmark Corporation Information
Table 106. Glenmark Description and Business Overview
Table 107. Glenmark Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Glenmark Gabapentin Drug Product
Table 109. Glenmark Recent Developments/Updates
Table 110. Amneal Pharmaceuticals Corporation Information
Table 111. Amneal Pharmaceuticals Description and Business Overview
Table 112. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Amneal Pharmaceuticals Gabapentin Drug Product
Table 114. Amneal Pharmaceuticals Recent Developments/Updates
Table 115. Aurobindo Pharma Corporation Information
Table 116. Aurobindo Pharma Description and Business Overview
Table 117. Aurobindo Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Aurobindo Pharma Gabapentin Drug Product
Table 119. Aurobindo Pharma Recent Developments/Updates
Table 120. Zydus Pharmaceuticals Corporation Information
Table 121. Zydus Pharmaceuticals Description and Business Overview
Table 122. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Zydus Pharmaceuticals Gabapentin Drug Product
Table 124. Zydus Pharmaceuticals Recent Developments/Updates
Table 125. Hi-Tech Pharmaceuticals Corporation Information
Table 126. Hi-Tech Pharmaceuticals Description and Business Overview
Table 127. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Hi-Tech Pharmaceuticals Gabapentin Drug Product
Table 129. Hi-Tech Pharmaceuticals Recent Developments/Updates
Table 130. Marksans Pharma Corporation Information
Table 131. Marksans Pharma Description and Business Overview
Table 132. Marksans Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Marksans Pharma Gabapentin Drug Product
Table 134. Marksans Pharma Recent Developments/Updates
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Business Overview
Table 137. Mylan Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Mylan Gabapentin Drug Product
Table 139. Mylan Recent Developments/Updates
Table 140. InvaGen Pharmaceuticals Corporation Information
Table 141. InvaGen Pharmaceuticals Description and Business Overview
Table 142. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. InvaGen Pharmaceuticals Gabapentin Drug Product
Table 144. InvaGen Pharmaceuticals Recent Developments/Updates
Table 145. Alkem Laboratories Corporation Information
Table 146. Alkem Laboratories Description and Business Overview
Table 147. Alkem Laboratories Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Alkem Laboratories Gabapentin Drug Product
Table 149. Alkem Laboratories Recent Developments/Updates
Table 150. Tris Pharma Corporation Information
Table 151. Tris Pharma Description and Business Overview
Table 152. Tris Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Tris Pharma Gabapentin Drug Product
Table 154. Tris Pharma Recent Developments/Updates
Table 155. ACI HealthCare Limited Corporation Information
Table 156. ACI HealthCare Limited Description and Business Overview
Table 157. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. ACI HealthCare Limited Gabapentin Drug Product
Table 159. ACI HealthCare Limited Recent Developments/Updates
Table 160. Jiangsu Hengrui Medicine Corporation Information
Table 161. Jiangsu Hengrui Medicine Description and Business Overview
Table 162. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 163. Jiangsu Hengrui Medicine Gabapentin Drug Product
Table 164. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 165. CSPC Ouyi Pharmaceutical Corporation Information
Table 166. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 167. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 168. CSPC Ouyi Pharmaceutical Gabapentin Drug Product
Table 169. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 170. Sciegen Pharmaceuticals Corporation Information
Table 171. Sciegen Pharmaceuticals Description and Business Overview
Table 172. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 173. Sciegen Pharmaceuticals Gabapentin Drug Product
Table 174. Sciegen Pharmaceuticals Recent Developments/Updates
Table 175. Epic Pharma Corporation Information
Table 176. Epic Pharma Description and Business Overview
Table 177. Epic Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 178. Epic Pharma Gabapentin Drug Product
Table 179. Epic Pharma Recent Developments/Updates
Table 180. Lupin Limited Corporation Information
Table 181. Lupin Limited Description and Business Overview
Table 182. Lupin Limited Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 183. Lupin Limited Gabapentin Drug Product
Table 184. Lupin Limited Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Gabapentin Drug Distributors List
Table 188. Gabapentin Drug Customers List
Table 189. Gabapentin Drug Market Trends
Table 190. Gabapentin Drug Market Drivers
Table 191. Gabapentin Drug Market Challenges
Table 192. Gabapentin Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gabapentin Drug
Figure 2. Global Gabapentin Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Gabapentin Drug Market Share by Type in 2022 & 2029
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Gabapentin Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Gabapentin Drug Market Share by Application in 2022 & 2029
Figure 9. Postherpetic Neuralgia in Adults
Figure 10. Partial Onset Seizures
Figure 11. Others
Figure 12. Global Gabapentin Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gabapentin Drug Market Size (2018-2029) & (US$ Million)
Figure 14. Global Gabapentin Drug Sales (2018-2029) & (K Units)
Figure 15. Global Gabapentin Drug Average Price (USD/Unit) & (2018-2029)
Figure 16. Gabapentin Drug Report Years Considered
Figure 17. Gabapentin Drug Sales Share by Manufacturers in 2022
Figure 18. Global Gabapentin Drug Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Gabapentin Drug Players: Market Share by Revenue in 2022
Figure 20. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Gabapentin Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Gabapentin Drug Sales Market Share by Country (2018-2029)
Figure 23. North America Gabapentin Drug Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Gabapentin Drug Sales Market Share by Country (2018-2029)
Figure 27. Europe Gabapentin Drug Revenue Market Share by Country (2018-2029)
Figure 28. Germany Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Gabapentin Drug Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Gabapentin Drug Revenue Market Share by Region (2018-2029)
Figure 35. China Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Gabapentin Drug Sales Market Share by Country (2018-2029)
Figure 46. Latin America Gabapentin Drug Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Gabapentin Drug Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Gabapentin Drug Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Gabapentin Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Gabapentin Drug by Type (2018-2029)
Figure 56. Global Revenue Market Share of Gabapentin Drug by Type (2018-2029)
Figure 57. Global Gabapentin Drug Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Gabapentin Drug by Application (2018-2029)
Figure 59. Global Revenue Market Share of Gabapentin Drug by Application (2018-2029)
Figure 60. Global Gabapentin Drug Price (USD/Unit) by Application (2018-2029)
Figure 61. Gabapentin Drug Value Chain
Figure 62. Gabapentin Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed